IL6 and rheumatoid arthritis: Tocilizumab [TCZ, (Roche Pharma (Schweiz) Ltd., S20171024)], a human monoclonal antibody directed against IL-6, has been commonly used in the therapy of rheumatoid arthritis (RA) (Biggioggero et al., 2018).